The expression of Fhl1 is downregulated in several cancers such as lung, prostate, breast, ovarian, colon, thyroid, brain, kidney, liver, and skin (melanoma), as well as oral cancers. Here, FHL1 is linked to lip and oral cavity carcinoma.